R. Chandupatla

Novel antibody against low‐n oligomers of tau protein promotes clearance of tau in cells via lysosomes

E. Mandelkow, R. Feederle, S. Kaniyappan, 2020, Alzheimer's & dementia.

Additional file 5: Figure S5. of The release and trans-synaptic transmission of Tau via exosomes

E. Mandelkow, E. Mandelkow, W. Maetzler, 2017 .

The release and trans-synaptic transmission of Tau via exosomes

Anja Schneider, Walter Maetzler, Stephan Irsen, 2017, Molecular Neurodegeneration.

Extracellular low-n oligomers of tau cause selective synaptotoxicity without affecting cell viability

E. Mandelkow, E. Mandelkow, S. Kaniyappan, 2017, Alzheimer's & Dementia.

Suppressing Tau Aggregation and Toxicity by an Anti-Aggregant Tau Fragment

E. Mandelkow, E. Mandelkow, S. Kaniyappan, 2018, Molecular Neurobiology.

A novel D-amino acid peptide with therapeutic potential (ISAD1) inhibits aggregation of neurotoxic disease-relevant mutant Tau and prevents Tau toxicity in vitro

Anselm H. C. Horn, E. Mandelkow, H. Sticht, 2022, Alzheimer's research & therapy.

Purification and Characterization of Low-n Tau Oligomers.

E. Mandelkow, S. Kaniyappan, R. Chandupatla, 2018, Methods in molecular biology.

FRET-based Tau seeding assay does not represent prion-like templated assembly of Tau filaments

E. Mandelkow, E. Mandelkow, J. Biernat, 2020, bioRxiv.